These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23647271)

  • 61. New Developments in Liposomal Drug Delivery.
    Pattni BS; Chupin VV; Torchilin VP
    Chem Rev; 2015 Oct; 115(19):10938-66. PubMed ID: 26010257
    [No Abstract]   [Full Text] [Related]  

  • 62. Recent developments in liposomal drug delivery systems for the treatment of retinal diseases.
    Urquhart AJ; Eriksen AZ
    Drug Discov Today; 2019 Aug; 24(8):1660-1668. PubMed ID: 30958994
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interview with Frank Ivy Carroll.
    Carroll FI; Coaker H
    Future Med Chem; 2013 Jun; 5(10):1083-8. PubMed ID: 23795966
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The second annual symposium on nanomedicine and drug delivery: exploring recent developments and assessing major advances. 19-20 August 2004, Polytechnic University, Brooklyn, NY, USA.
    Vinogradov S
    Expert Opin Drug Deliv; 2004 Nov; 1(1):181-4. PubMed ID: 16296729
    [TBL] [Abstract][Full Text] [Related]  

  • 65. How nanomedicine can be used in the treatment of tumors: an interview with Dr Gang Zheng.
    Zheng G; Overchuk M
    Nanomedicine (Lond); 2018 Nov; 13(22):2817-2820. PubMed ID: 30421644
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Proceedings of the Eighth International Nanomedicine and Drug Delivery Symposium (NanoDDS'10). October 3-5, 2010. Omaha, Nebraska, USA.
    J Control Release; 2011 Jul; 153(1):1-102. PubMed ID: 22081805
    [No Abstract]   [Full Text] [Related]  

  • 67. Drug delivery, biomaterials and nanomedicine: an interview with Daniel S Kohane.
    Kohane DS
    Future Sci OA; 2016 Sep; 2(3):FSO138. PubMed ID: 28031981
    [No Abstract]   [Full Text] [Related]  

  • 68. On language.
    Pinker S
    J Cogn Neurosci; 1994; 6(1):92-8. PubMed ID: 23962333
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cell adhesion molecules as therapeutic targets: interview with Professor Michael P Schön. Interviewed by Emma Quigley.
    Schön MP
    Expert Opin Ther Targets; 2006 Dec; 10(6):799-802. PubMed ID: 17105368
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Magnetic carriers conference 2008.
    Saatchi K; Häfeli UO
    Nanomedicine (Lond); 2008 Aug; 3(4):415-21. PubMed ID: 18694304
    [No Abstract]   [Full Text] [Related]  

  • 71. Interview: Nanomedicine and the fight against HIV/AIDS.
    Nel A; Swindells S; Bronich T; Gendelman HE
    Nanomedicine (Lond); 2014 Feb; 9(2):193-206. PubMed ID: 24552561
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nanosilicon for nanomedicine: a step towards biodegradable electronic implants?
    Canham L
    Nanomedicine (Lond); 2013 Oct; 8(10):1573-6. PubMed ID: 24074387
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Liposomes as ocular drug delivery systems].
    Carvalho EL; De la Fuente M; Seijo Rey B
    Arch Soc Esp Oftalmol; 2004 Apr; 79(4):151-2. PubMed ID: 15124069
    [No Abstract]   [Full Text] [Related]  

  • 74. Formulation and delivery solutions for the next generation biotherapeutics.
    Mastrobattista E
    J Control Release; 2021 Aug; 336():583-597. PubMed ID: 34174354
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An interview with Charles Cantor: achievements and advice from 50 years of biotechnology expertise.
    Cantor C
    Expert Rev Mol Diagn; 2015 Jun; 15(6):721-3. PubMed ID: 25990928
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Liposomes in vivo: prospects for liposome-based pharmaceuticals in the 1990s.
    Senior JH
    Biotechnol Genet Eng Rev; 1990; 8():279-317. PubMed ID: 2094273
    [No Abstract]   [Full Text] [Related]  

  • 77. Liposome advances - Sixth International Conference. Progress in drug and vaccine delivery.
    Storm G
    IDrugs; 2004 Feb; 7(2):122-4. PubMed ID: 15057653
    [No Abstract]   [Full Text] [Related]  

  • 78. Drug therapy smartens up.
    Martin C
    Nat Nanotechnol; 2015 Nov; 10(11):910-1. PubMed ID: 26530018
    [No Abstract]   [Full Text] [Related]  

  • 79. Selective drug delivery systems.
    Mayhew E
    Invest Radiol; 1988 Mar; 23(3):229-32. PubMed ID: 3286572
    [No Abstract]   [Full Text] [Related]  

  • 80. Overcoming the challenges of RNAi-based therapy: an interview with James Hamilton.
    Hamilton J
    Ther Deliv; 2018 Jul; 9(7):511-513. PubMed ID: 29943684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.